Parnaparin sodium
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
What is known and Objective: The most common complication of heparin therapy is bleeding. Allergic reactions to heparin are rare…
Aliment Pharmacol Ther 31, 375‐386
CB-01-05-MMX (LMW Heparin MMX), being developed by Cosmo Pharmaceuticals SpA, is a novel oral parnaparin sodium formulation for…
Background Efficacy of heparin and low‐molecular‐weight heparins (LMWHs) in inflammatory bowel disease (IBD) treatment has been…
AbstractBackground: Acute myocardial infarction (AMI) is one of the most serious cardiovascular diseases, with acute ST-segment…
BACKGROUND
This study sought to compare the efficacy of low molecular weight heparin, parnaparin and unfractionated heparin in…
SummarySynopsisParnaparin is a low molecular weight (LMW) heparin which, like other members of its class, apparently demonstrates…
Hemodialysis was performed on dogs, following intravenous bolus injections of LHG at dosage levels of 50, 100 and 200 IU/kg and…